5 More biologic therapy for pregnant women! (www.fda.gov) posted 2 years ago by Thisisnotanexit 2 years ago by Thisisnotanexit +5 / -0 ABRYSVO ABRYSVO is indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. 1 comment share 1 comment share save hide report block hide replies
Watch out world. I'm serious, this is stupid.